Bioceres Crop Solutions Corp. - (BIOX) closed at $0.21 on November 5, 2026, down 16.0% from the previous close, on volume of 193,195 shares (30-day average 198,045).
Data as of November 5, 2026.
No headlines found.
Business Wire (Mon, 14-Sep 6:44 PM ET)
Bioceres Crop Solutions Corp develops and commercializes productivity solutions designed to improve crop performance and support more sustainable agricultural practices. It has a broad biotech platform with high-impact, licensed and patented technologies for seeds and microbial ag-inputs, as well as biological and next-generation conventional crop nutrition and protection solutions. Its segments include crop protection consisting of Adjuvants and Pest control molecules; Seed and Integrated products consisting of Seed treatment packs, Seed traits, and Seed germplasm; and Crop Nutrition consisting of microbead fertilizers, Inoculants, Biofertilizers, and Crop health products and biostimulants. It derives the maximum revenue from the crop protection segment.
Bioceres Crop Solutions Corp. - trades on the NASDAQ stock market under the symbol BIOX.
As of November 6, 2026, BIOX stock price climbed to $0.22 with 38,431 million shares trading.
BIOX has a beta of 2.74, meaning it tends to be more sensitive to market movements. BIOX has a correlation of 0.13 to the broad based SPY ETF.
BIOX has a market cap of $13.30 million. This is considered a Sub-Micro Cap stock.
Last quarter Bioceres Crop Solutions Corp. - reported $56 million in Revenue and -$.50 earnings per share. This fell short of revenue expectation by $-23 million and missed earnings estimates by -$.44.
In the last 3 years, BIOX traded as high as $14.05 and as low as $.19.
The top ETF exchange traded funds that BIOX belongs to (by Net Assets): ARGT.
BIOX has underperformed the market in the last year with a price return of -87.5% while the SPY ETF gained +10.3%. BIOX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -39.6% and -13.7%, respectively, while the SPY returned -3.6% and -3.1%, respectively.
BIOX support price is $.19 and resistance is $.23 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BIOX shares will trade within this expected range on the day.